| Primary |
| Herpes Zoster |
44.9% |
| Necrotising Retinitis |
7.9% |
| Hiv Infection |
7.1% |
| Hypertension |
6.3% |
| Agranulocytosis |
4.7% |
| Acute Myeloid Leukaemia |
3.9% |
| Chronic Fatigue Syndrome |
3.1% |
| Diabetes Mellitus |
3.1% |
| Eye Disorder |
2.4% |
| Oral Herpes |
2.4% |
| Psoriasis |
2.4% |
| Antiviral Prophylaxis |
1.6% |
| Genital Herpes |
1.6% |
| Herpes Simplex |
1.6% |
| Infection Prophylaxis |
1.6% |
| Inflammation |
1.6% |
| Lower Respiratory Tract Infection |
1.6% |
| Arthralgia |
0.8% |
| Bronchitis |
0.8% |
| Cardiac Disorder |
0.8% |
|
| Vasculitis |
10.0% |
| Angioedema |
8.0% |
| Leukocytoclastic Vasculitis |
8.0% |
| Tremor |
8.0% |
| Altered State Of Consciousness |
6.0% |
| Coordination Abnormal |
6.0% |
| Palpitations |
6.0% |
| Vomiting |
6.0% |
| Blood Creatinine Increased |
4.0% |
| Condition Aggravated |
4.0% |
| Rash |
4.0% |
| Rhinorrhoea |
4.0% |
| Skin Disorder |
4.0% |
| Skin Oedema |
4.0% |
| Treatment Noncompliance |
4.0% |
| Visual Disturbance |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Agitation |
2.0% |
| Anaphylactic Reaction |
2.0% |
| Asthenia |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
27.5% |
| Hiv Infection |
12.7% |
| Necrotising Retinitis |
10.6% |
| Lower Respiratory Tract Infection |
7.7% |
| Herpes Zoster |
7.0% |
| Drug Use For Unknown Indication |
6.3% |
| Crohn's Disease |
5.6% |
| Retinal Disorder |
4.2% |
| Antiretroviral Therapy |
2.8% |
| Rash Macular |
2.8% |
| Arthropod Bite |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Genital Herpes |
2.1% |
| Graft Versus Host Disease |
1.4% |
| Herpes Simplex |
1.4% |
| Angioedema |
0.7% |
| Aplastic Anaemia |
0.7% |
| Cough |
0.7% |
| Diabetes Mellitus |
0.7% |
| Eye Disorder |
0.7% |
|
| Renal Impairment |
14.8% |
| Visual Acuity Reduced |
11.1% |
| Completed Suicide |
7.4% |
| Necrotising Retinitis |
7.4% |
| Altered State Of Consciousness |
3.7% |
| Angioedema |
3.7% |
| Aspartate Aminotransferase Increased |
3.7% |
| Cataract |
3.7% |
| Chest Discomfort |
3.7% |
| Death |
3.7% |
| Drug Toxicity |
3.7% |
| Intentional Drug Misuse |
3.7% |
| Intentional Overdose |
3.7% |
| Nephropathy Toxic |
3.7% |
| Ophthalmic Herpes Zoster |
3.7% |
| Pyrexia |
3.7% |
| Rash |
3.7% |
| Rash Erythematous |
3.7% |
| Rash Macular |
3.7% |
| Rash Maculo-papular |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.6% |
| Product Used For Unknown Indication |
16.2% |
| Premedication |
7.6% |
| Hiv Infection |
5.4% |
| Prophylaxis |
5.2% |
| Acute Lymphocytic Leukaemia |
4.8% |
| T-cell Lymphoma |
4.1% |
| Peripheral T-cell Lymphoma Unspecified |
4.0% |
| Infection Prophylaxis |
4.0% |
| Pain |
3.3% |
| Hypertension |
2.9% |
| Multiple Myeloma |
2.1% |
| Constipation |
2.0% |
| Chronic Lymphocytic Leukaemia |
1.8% |
| Antiviral Prophylaxis |
1.5% |
| Herpes Zoster |
1.5% |
| Antifungal Prophylaxis |
1.4% |
| Hepatosplenic T-cell Lymphoma |
1.3% |
| Depression |
1.3% |
| Anxiety |
1.2% |
|
| Oedema Peripheral |
14.3% |
| White Blood Cell Count Decreased |
10.1% |
| Vomiting |
8.9% |
| Sepsis |
7.7% |
| Tumour Lysis Syndrome |
7.1% |
| Death |
5.4% |
| Venous Thrombosis Limb |
5.4% |
| Pancytopenia |
4.8% |
| Urinary Tract Infection |
4.2% |
| Endometrial Cancer Stage Ii |
3.6% |
| Cardiac Failure |
3.0% |
| Chest Pain |
3.0% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
3.0% |
| Myocardial Infarction |
3.0% |
| Thrombocytopenia |
3.0% |
| Tooth Repair |
3.0% |
| Tuberculosis |
3.0% |
| Weight Increased |
3.0% |
| Febrile Neutropenia |
2.4% |
| Hyperkalaemia |
2.4% |
|
